Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioNTech SE ADR buy MoneyMoney

BioNTech SE ADR
Start price
€67.74
13.07.20 / 0%
Target price
€250.00
04.11.21
Performance (%)
254.74%
End price
€240.30
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €240.30. With a performance of 254.74% the BUY prediction by MoneyMoney was a big success. MoneyMoney has a follow-up prediction for BioNTech SE ADR where he still thinks BioNTech SE ADR is a Buy.
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® -0.922% -1.993% 13.399% 16.075%
iShares Nasdaq 100 0.371% -0.868% 41.541% 46.938%
iShares Nikkei 225® 2.224% -5.187% 20.497% 4.643%
iShares S&P 500 -0.026% -0.918% 30.410% 42.418%

According to MoneyMoney what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Differentiated customer and product portfolio
Valuable balance sheet
High Investments for future growth
Future proof or reliable business model
Capable Management
Innovative
Growths faster than the competition
Stable Large shareholder and/or long term investor
Revenue growth > 30% per year expected
Well known brand
Top 10 in its market
Could be worthwhile Investment >10% per year
Good culture
Strong uniques
positive Cash Flow expected
Sustainability is important
Good rating
Cons
Higher risks for its business
Significant cyclical dependencies
Low dividend yield expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital

Comments by MoneyMoney for this prediction

In the thread Trading Biontech SE
Prediction Buy
Perf. (%) 254.74%
Target price 250.000
Change
Ends at 04.11.21

Die von MoneyMoney gewählte maximale Laufzeit wurde überschritten

MoneyMoney 
0
Report Share
05.11.21

Current prediction by MoneyMoney for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€81.35
18.04.24
€100.00
18.04.25
5.96%
03.05.24

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
18.04.24 0%